Amanda Campos
Pediatric Endocrinology · Phoenix, AZNPI 1053653113
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.
Across 149 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$621
- BETA Bionics, Inc.$261
- Tandem Diabetes Care, Inc.$207
- Medtronic$196
- Novo Nordisk$181
- Pfizer$174
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,18398%
- Education$612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $621 |
| BETA Bionics, Inc. | 4 | $261 |
| Tandem Diabetes Care, Inc. | 8 | $207 |
| Medtronic(2 entities) | 8 | $196 |
| Novo Nordisk | 11 | $181 |
| Pfizer | 10 | $174 |
| Rhythm Pharmaceuticals, Inc. | 4 | $173 |
| Sanofi-aventis U.S. LLC | 3 | $168 |
| Insulet Corporation | 4 | $151 |
| Dexcom, Inc. | 7 | $149 |
| Abbott | 9 | $148 |
| Arbor Pharmaceuticals, Inc. | 5 | $113 |
| Ascensia Diabetes Care US Inc. | 1 | $98 |
| Ascendis Pharma Endocrinology Inc | 1 | $96 |
| Sequel Med Tech, LLC | 1 | $73 |
| Xeris Pharmaceuticals, Inc. | 4 | $65 |
| Lilly USA, LLC | 4 | $63 |
| Intuity Medical Inc | 2 | $58 |
| Tolmar, Inc. | 3 | $53 |
| Ultragenyx Pharmaceutical Inc. | 2 | $49 |
| Eton Pharmaceuticals, Inc. | 2 | $39 |
| Tolmar Pharmaceuticals, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Biomarin Pharmaceutical Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,244 in reported general payments places this provider in the 70th percentile of 35 pediatric endocrinology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 14 | $492 |
| Testosterone Cypionate | 12 | $173 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Phoenix
- Eileen Baez IrizarryPhoenix$53K
- Pamela SmithPhoenix$26K
- Chirag KapadiaPhoenix$13K
- Grazyna Piekos-SobczakPhoenix$12K
- Rola SaadPhoenix$10K
- Micah OlsonPhoenix$9K
- Rochelle WilsonPhoenix$4K
- Mahmoud KabbaniPhoenix$3K
- Melissa ChambersPhoenix$3K
- Dorothee NewbernPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.